Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotype

To describe the Alzheimer disease (AD)‐like clinical and pathological features, including marked neurofibrillary tangle (NFT) pathology, of a familial prion disease due to a rare nonsense mutation of the prion gene (PRNP).

[1]  J. Ironside,et al.  Human prion disease , 2020, Definitions.

[2]  Bernardino Ghetti,et al.  Gerstmann–Sträussler–Scheinker Disease , 2011 .

[3]  F. Baas,et al.  Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP , 2009, Acta Neuropathologica.

[4]  S. Terada,et al.  Coexistence of Creutzfeldt‐Jakob disease, Lewy body disease, and Alzheimer's disease pathology: An autopsy case showing typical clinical features of Creutzfeldt‐Jakob disease , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

[5]  G. Plant,et al.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies , 2009, Acta Neuropathologica.

[6]  T. Montine,et al.  RESEARCH ARTICLE: Empiric Refinement of the Pathologic Assessment of Lewy‐Related Pathology in the Dementia Patient , 2008, Brain pathology.

[7]  J. Hauw,et al.  A sporadic case of Creutzfeldt–Jakob disease with beta‐amyloid deposits and alpha‐synuclein inclusions , 2007, Neuropathology : official journal of the Japanese Society of Neuropathology.

[8]  Bernardino Ghetti,et al.  Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles , 1994, Molecular Neurobiology.

[9]  E. Cochran,et al.  Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2004 .

[10]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[11]  D. Dickson,et al.  Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders: Dickson/Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2011 .

[12]  B. Ghetti,et al.  A 7-kDa Prion Protein (PrP) Fragment, an Integral Component of the PrP Region Required for Infectivity, Is the Major Amyloid Protein in Gerstmann-Sträussler-Scheinker Disease A117V* , 2001, The Journal of Biological Chemistry.

[13]  R. Nitsch,et al.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. , 2000, American journal of human genetics.

[14]  E. Cochran,et al.  Allelic origin of the abnormal prion protein isoform in familial prion diseases , 1997, Nature Medicine.

[15]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. S. St George-Hyslop,et al.  Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165 , 1995, Journal of neuropathology and experimental neurology.

[17]  B. Ghetti,et al.  Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish Kindreds) express only PrP peptides encoded by the mutant allele , 1994, Cell.

[18]  S. Prusiner.  Inherited prion diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Heyman,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.

[20]  J. Trojanowski,et al.  A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred , 1993, Brain Research.

[21]  J. Collinge.  Inherited prion diseases. , 1993, Advances in neurology.

[22]  S. Prusiner,et al.  Prion biology and diseases. , 1999, Harvey lectures.

[23]  B. Ghetti,et al.  Gerstmann‐Sträussler‐Scheinker disease II. Neurofibrillary tangles and plaques with PrP‐amyloid coexist in an affected family , 1989, Neurology.

[24]  T. Crow,et al.  DIAGNOSIS OF GERSTMANN-STRÄUSSLER SYNDROME IN FAMILIAL DEMENTIA WITH PRION PROTEIN GENE ANALYSIS , 1989, The Lancet.

[25]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[26]  S. Prusiner,et al.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[27]  R. Katzman.,et al.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. , 1983, The American journal of psychiatry.

[28]  Pl Lantos,et al.  Greenfield's Neuropathology , 1985 .

[29]  J. Hellstrom.  Stones in the kidney and ureter. , 1948, Lancet.